Mario Germano Giuliani, Director, 10% Owner at Royalty Pharma plc (RPRX), sold 1,047,684 shares at $41.02 ($43.0M) on 2022-09-20, disclosed to the SEC on 2022-09-22.
Open-market sale of $43.0M RPRX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.02 | 130,330 | $5.3M | 12.4% |
| 2 | $41.02 | 130,330 | $5.3M | 12.4% |
| 3 | $41.02 | 267,815 | $11.0M | 25.5% |
| 4 | $41.02 | 267,815 | $11.0M | 25.5% |
| 5 | $41.25 | 125,697 | $5.2M | 12.0% |
| 6 | $41.25 | 125,697 |
| $5.2M |
| 12.0% |
| Total | $41.08 avg | 1,047,684 | $43.0M | 100% |
| Filing → |
| RPRX | SELL | 2022-09-20 | $32.2M | — | Filing → |
| RPRX | SELL | 2022-09-16 | $29.2M | — | Filing → |
| RPRX | BUY | 2020-06-22 | $1.4M | — | Filing → |